Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 467

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

High 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer

Johansson, Jan-Erik·1992·JAMA: The Journal of the American Medical Association

Abstract

OBJECTIVE: To learn about the natural history of untreated, early-stage prostatic cancer. DESIGN: Cohort study with a mean follow-up of 123 months (range, 81 to 165 months). SETTING: Population-based, regionally well defined. PATIENTS: A consecutive sample of 223 patients (98% of all eligible) with early-stage (T0-2, NX, M0), initially untreated prostatic cancer. MAIN OUTCOME MEASURES: Progression-free, disease-specific, and overall survival. Need for palliative and terminal care. INTERVENTION: Patients with tumor progression were hormonally treated (orchiectomy or estrogens) if they had symptoms. RESULTS: After complete follow-up, only 19 (8.5%) of the 223 patients had died of prostate cancer and 105 (85%) of a total of 124 deaths were from other causes. The 10-year, disease-specific survival rate was 86.8% (95% confidence interval, 80.7% to 92.9%) and was equally high (87.9%) in a subgroup of 58 patients who met current indications for radical prostatectomy. The progression-free, 10-year survival rate was 53.1% (95% confidence interval, 44.2% to 62.0%). In 50 of 76 patients, local growth provided the only evidence of progression, and endocrine treatment was generally successful in these cases. Following an initial increase, the rate of disease progression and death from prostate cancer decreased during the last years of follow-up. CONCLUSION: The low disease-specific mortality rate, especially in patients with highly and moderately differentiated tumors, means that any local or systemic therapy intended for patients with early prostatic cancer must be evaluated in clinical trials with untreated controls for comparison.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.1992.03480160049033

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 467

Metadata

Authors
Johansson, J.-E.
Venue
JAMA: The Journal of the American Medical Association
Published
1992-04-22
Volume
267
Issue
16
Pages
2191
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2064028125
Cited by
467
References
8
FWCI
78.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer. https://app.cochat.ai/papers/10.1001/jama.1992.03480160049033
The paper
Johansson, J.-E. (1992). High 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1992.03480160049033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.